Subgingival doxycycline: Will start two Phase III trials

Atrix Laboratories Inc. (ATRX), Fort Collins, Colo. Product: Subgingival doxycycline Indication: Periodontitis Status: Will start two Phase III trials in early 1995 in a total of 800 patients, compar...